Dr. Apostolos Papachristos received his PharmD from the National and Kapodistrian University of Athens, Greece. Subsequently, he completed his Ph.D. at the University of Patras, Greece, and his postdoctoral fellowship in Clinical Pharmacology and Pharmacogenomics at the University of Chicago, USA. He is a diplomate of the American Board of Clinical Pharmacology and board-certified in oncology pharmacy from the Board of Pharmacy S[pecialties. His research focuses on drug development, pharmacogenomics, precision medicine, microbiome, and personalized therapeutics.